Publikationen in Zusammenarbeit mit Forschern von Hospital de Cruces (26)

2018

  1. Infective endocarditis in a patient with metastatic colorectal cancer

    Revista Espanola de Quimioterapia

2015

  1. Efficacy and safety of fixed-dose-rate infusions of gemcitabine plus erlotinib for advanced pancreatic cancer

    Journal of Analytical Oncology, Vol. 4, Núm. 1, pp. 44-51

2014

  1. Bevacizumab in combination with FOLFIRI in the first-line treatment of patients with advanced colorectal cancer: A single-institution experience

    Journal of Analytical Oncology, Vol. 3, Núm. 1, pp. 26-32

  2. Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: Biological basis and therapeutic strategies

    Clinical and Translational Oncology, Vol. 16, Núm. 4, pp. 339-350

2013

  1. Thymidylate Synthase Expression Determines Pemetrexed Targets and Resistance Development in Tumour Cells

    PLoS ONE, Vol. 8, Núm. 5

2012

  1. Molecular mechanism implicated in Pemetrexed-induced apoptosis in human melanoma cells

    Molecular Cancer, Vol. 11

2010

  1. Fixed-dose-rate gemcitabine infusion in patients with advanced pancreatic or biliary tree adenocarcinoma

    Tumori, Vol. 96, Núm. 3, pp. 405-410

2008

  1. Prognostic factors in cancer of unknown primary site

    Clinical and Translational Oncology

2007

  1. Efficacy and safety of cisplatin and capecitabine in combination as first line treatment for unselected patients with advanced gastric cancer [3]

    Acta Oncologica

2006

  1. Oxaliplatin overdosage successfully recovered with mild toxicities [1]

    Acta Oncologica

  2. Paclitaxel for progressive basal cell carcinoma [4]

    Journal of the American Academy of Dermatology, Vol. 54, Núm. 2 SUPPL.

2005

  1. Biweekly administration of cisplatin/gemcitabine in advanced nonsmall cell lung cancer

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 28, Núm. 5, pp. 501-507

  2. Extravasation of docetaxel: A red hand syndrome

    Archives of Dermatology

2004

  1. Factores pronósticos y predictivos en pacientes con cáncer de origen desconocido tratados con un esquema de quimioterapia con paclitaxel

    Medicina Clinica, Vol. 122, Núm. 6, pp. 216-218

  2. Preradiation chemotherapy with VM-26 and CCNU in patients with glioblastoma multiforme

    Tumori, Vol. 90, Núm. 6, pp. 562-566

  3. ¿Y qué es lo mejor para el paciente con cáncer de pulmón?

    Archivos de Bronconeumologia

2003

  1. A novel biweekly schedule with cisplatin and gemcitabine in advanced non-small cell lung cancer

    International Journal of Clinical Pharmacology Research, Vol. 23, Núm. 1, pp. 9-16

  2. Amyloidosis and lung cancer

    Clinical Lung Cancer, Vol. 4, Núm. 4, pp. 249-251

  3. Onycholysis associated with capecitabine in combination with irinotecan in two patients with colorectal cancer [3]

    Journal of the National Cancer Institute

2002

  1. Gemcitabine and vascular toxicity [2]

    Lung Cancer